Literature DB >> 3341500

Vaccination against poliomyelitis: present possibilities and future prospects.

J L Melnick1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341500      PMCID: PMC1349182          DOI: 10.2105/ajph.78.3.304

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  12 in total

1.  Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3.

Authors:  M Ferguson; D M Evans; D I Magrath; P D Minor; J W Almond; G C Schild
Journal:  Virology       Date:  1985-06       Impact factor: 3.616

2.  Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.

Authors:  P D Minor; D M Evans; M Ferguson; G C Schild; G Westrop; J W Almond
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

3.  Recombinants between attenuated and virulent strains of poliovirus type 1: derivation and characterization of recombinants with centrally located crossover points.

Authors:  V I Agol; S G Drozdov; V P Grachev; M S Kolesnikova; V G Kozlov; N M Ralph; L I Romanova; E A Tolskaya; A V Tyufanov; E G Viktorova
Journal:  Virology       Date:  1985-06       Impact factor: 3.616

4.  Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome.

Authors:  V R Racaniello; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

5.  Cloned poliovirus complementary DNA is infectious in mammalian cells.

Authors:  V R Racaniello; D Baltimore
Journal:  Science       Date:  1981-11-20       Impact factor: 47.728

6.  Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides.

Authors:  E A Emini; B A Jameson; E Wimmer
Journal:  Nature       Date:  1983 Aug 25-31       Impact factor: 49.962

7.  Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark.

Authors:  H von Magnus; I Petersen
Journal:  Rev Infect Dis       Date:  1984 May-Jun

8.  Polio immunization policy in the United States: a new challenge for a new generation.

Authors:  D Salk
Journal:  Am J Public Health       Date:  1988-03       Impact factor: 9.308

9.  Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1.

Authors:  S van der Werf; C Wychowski; P Bruneau; B Blondel; R Crainic; F Horodniceanu; M Girard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1.

Authors:  C Wychowski; S van der Werf; O Siffert; R Crainic; P Bruneau; M Girard
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  2 in total

1.  A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas.

Authors:  T Tulchinsky; Y Abed; S Shaheen; N Toubassi; Y Sever; M Schoenbaum; R Handsher
Journal:  Am J Public Health       Date:  1989-12       Impact factor: 9.308

2.  New dimensions in vaccinology: A new insight.

Authors:  D Tomar; V Chattree; V Tripathi; A A Khan; A R Bakshi; D N Rao
Journal:  Indian J Clin Biochem       Date:  2005-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.